| abstract |
It is an object of the present invention to provide an agent for the treatment and / or prophylaxis of congestion comprising as an active ingredient a compound (EP 1 antagonist) having an antagonistic action against the EP 1 receptor, which is one of the prostaglandin E 2 receptor subtypes.n n n EP 1 antagonists are useful for the treatment of depression (eg, endogenous, reactive, weathering, neurodepressive, depressive states of cerebral mental disorders). |